Japan, Sept. 7 -- UNIV OF ULSTER has got intellectual property rights for 'BISPECIFIC ANTIBODY TARGETING IL-1R1 AND NLPR3.' Other related details are as follows:
Application Number: JP,2024-104327
Category (FI): A61P3/10,A61P1/04,A61P27/04,A61K39/395@N,A61K39/395@D,C12N15/13,C12N15/62@Z,C07K16/18,A61P9/10,A61P43/00,111,A61P25/28,A61K38/02,C12P21/08,A61P19/02,A61P29/00,101,A61P35/00,A61P17/00,A61P27/06,A61P27/02,A61P9/10,101,A61P29/00,C07K16/28,C07K16/24,C07K16/46,A61P25/24,A61P25/16
Stage: Grant (IP right granted following substantive examination.)
Filing Date: June 27, 2024
Publication Date: Sept. 18, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication....